CRISPR May Not Be a One Size Fits All Therapy

GEN news Highlights, 12 December 2017,

CRISPR has been described as having the potential to revolutionize gene therapy, however innate genetic diversity may hinder mass produced treatments.  Natural variation in DNA sequence among patients indicates that CRISPR therapy may have to be individualized to avoid off-target effects and maximize efficacy.  With the first human CRISPR trials currently ongoing, we may have a better understanding of its therapeutic potential soon.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply